Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
暂无分享,去创建一个
Stephen Neidle | Gary N Parkinson | Gavin W Collie | M. Micco | G. Parkinson | S. Neidle | Rossella Promontorio | Sonja M Hampel | Marialuisa Micco | G. Collie | Sonja M. Hampel | Rossella Promontorio
[1] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[2] Sarah W. Burge,et al. Quadruplex DNA: sequence, topology and structure , 2006, Nucleic acids research.
[3] T. Lange,et al. Shelterin: the protein complex that shapes and safeguards human telomeres , 2005 .
[4] E. Gilson,et al. G-Quadruplex Ligand RHPS4 Potentiates the Antitumor Activity of Camptothecins in Preclinical Models of Solid Tumors , 2008, Clinical Cancer Research.
[5] A. Phan,et al. Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K+ solution† , 2007, Nucleic acids research.
[6] B. Guyen,et al. Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors. , 2004, Bioorganic & medicinal chemistry letters.
[7] A. Phan,et al. Structure of human telomeric DNA in crowded solution. , 2011, Journal of the American Chemical Society.
[8] K. Shin‐ya,et al. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. , 2006, Cancer research.
[9] J. Shay,et al. Telomerase: a target for cancer therapeutics. , 2002, Cancer cell.
[10] Salvatore Florio,et al. Design, synthesis, biophysical and biological studies of trisubstituted naphthalimides as G-quadruplex ligands. , 2011, Bioorganic & medicinal chemistry.
[11] G. Parkinson,et al. Topology conservation and loop flexibility in quadruplex-drug recognition: crystal structures of inter- and intramolecular telomeric DNA quadruplex-drug complexes. , 2008, Journal of molecular biology.
[12] M. Palumbo,et al. Quinone methides tethered to naphthalene diimides as selective G-quadruplex alkylating agents. , 2009, Journal of the American Chemical Society.
[13] T. Cech,et al. Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] David M. Prescott,et al. Inhibition of telomerase by G-quartet DMA structures , 1991, Nature.
[15] Stephen Neidle,et al. Structure of a G-quadruplex-ligand complex. , 2003, Journal of molecular biology.
[16] Roger A. Jones,et al. Structure of the Hybrid-2 type intramolecular human telomeric G-quadruplex in K+ solution: insights into structure polymorphism of the human telomeric sequence , 2007, Nucleic acids research.
[17] M. Palumbo,et al. Naphthalene diimide scaffolds with dual reversible and covalent interaction properties towards G-quadruplex. , 2011, Biochimie.
[18] T. Lange,et al. How shelterin solves the telomere end-protection problem. , 2010 .
[19] R. Vilar,et al. Stabilisation of G-quadruplex DNA by small molecules. , 2008, Current topics in medicinal chemistry.
[20] Stephen Neidle,et al. Structural basis of DNA quadruplex recognition by an acridine drug. , 2008, Journal of the American Chemical Society.
[21] S. Neidle,et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. , 1997, Journal of medicinal chemistry.
[22] Roger A. Jones,et al. Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution , 2006, Nucleic acids research.
[23] Jean-Louis Mergny,et al. Targeting telomeres and telomerase. , 2008, Biochimie.
[24] S. Neidle,et al. Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells. , 2010, Bioorganic & medicinal chemistry letters.
[25] J. Shay,et al. Targeting telomerase-expressing cancer cells , 2011, Journal of cellular and molecular medicine.
[26] S. Balasubramanian,et al. A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres. , 2008, Journal of the American Chemical Society.
[27] M. Teulade‐Fichou,et al. A hitchhiker's guide to G-quadruplex ligands. , 2008, Organic & biomolecular chemistry.
[28] Stephen Neidle,et al. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. , 2005, Cancer research.
[29] Jeffery T. Davis. G-quartets 40 years later: from 5'-GMP to molecular biology and supramolecular chemistry. , 2004, Angewandte Chemie.
[30] A. Schätzlein,et al. Targeting pancreatic cancer with a G-quadruplex ligand. , 2011, Bioorganic & medicinal chemistry.
[31] K. Shin‐ya,et al. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia , 2006, Oncogene.
[32] A. Phan. Human telomeric G‐quadruplex: structures of DNA and RNA sequences , 2010, The FEBS journal.
[33] S. Neidle,et al. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. , 2002, Molecular pharmacology.
[34] S. Neidle,et al. Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands. , 2008, Bioorganic & medicinal chemistry letters.
[35] Danzhou Yang,et al. Solution structure of a 2:1 quindoline-c-MYC G-quadruplex: insights into G-quadruplex-interactive small molecule drug design. , 2011, Journal of the American Chemical Society.
[36] Stephen Neidle,et al. Crystal structure of parallel quadruplexes from human telomeric DNA , 2002, Nature.
[37] Stephen Neidle,et al. Human telomeric G‐quadruplex: The current status of telomeric G‐quadruplexes as therapeutic targets in human cancer , 2010, The FEBS journal.
[38] Carlo Leonetti,et al. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. , 2007, The Journal of clinical investigation.
[39] Yu-hua Hao,et al. G-quadruplex formation at the 3′ end of telomere DNA inhibits its extension by telomerase, polymerase and unwinding by helicase , 2011, Nucleic acids research.
[40] L. Kèlland,et al. Targeting the Limitless Replicative Potential of Cancer: The Telomerase/Telomere Pathway , 2007, Clinical Cancer Research.
[41] J. Fletcher,et al. Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule. , 2009, Journal of medicinal chemistry.
[42] G. Parkinson,et al. Structural basis for binding of porphyrin to human telomeres. , 2007, Biochemistry.
[43] Roger A. Jones,et al. Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization. , 2005, Biochemistry.
[44] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[45] G. Parkinson,et al. Structural basis of telomeric RNA quadruplex--acridine ligand recognition. , 2011, Journal of the American Chemical Society.
[46] Stephen Neidle,et al. Selectivity in ligand recognition of G-quadruplex loops. , 2009, Biochemistry.
[47] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[48] A. Phan,et al. Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter. , 2004, Journal of the American Chemical Society.
[49] A. Phan,et al. Structure of the human telomere in K+ solution: a stable basket-type G-quadruplex with only two G-tetrad layers. , 2009, Journal of the American Chemical Society.